• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝硬化患者非肝脏手术相关的发病率和死亡率:一项系统综述。

Morbidity and mortality related to non-hepatic surgery in patients with liver cirrhosis: a systematic review.

机构信息

Erasmus University Medical Center, Department of Surgery, Medical Center, Rotterdam, The Netherlands.

出版信息

Best Pract Res Clin Gastroenterol. 2012 Feb;26(1):47-59. doi: 10.1016/j.bpg.2012.01.010.

DOI:10.1016/j.bpg.2012.01.010
PMID:22482525
Abstract

BACKGROUND

The aim of this study is to review systematically morbidity and mortality after non-hepatic surgery in patients with liver cirrhosis.

METHODS

Comprehensive searches were conducted in PubMed, Embase and the Cochrane Library for articles using the words: liver failure, hepatic insufficiency, liver cirrhosis, cirrhosis, cirrhotic, surgical procedures, operative complications, operative mortality, postoperative complications, surgical complication, surgical risk, hernia.

RESULTS

Forty-six articles were selected from 5247 included after the initial search. Level of evidence provided in the articles varied greatly. Non-hepatic surgery of patients with cirrhosis resulted in increased postoperative morbidity and mortality compared to similar surgery for non-cirrhotic patients. Cholecystectomy and umbilical and inguinal hernia correction were associated with the lowest increased morbidity and mortality while pancreatic surgery, cardiovascular, and trauma surgery correlated with the highest. The preoperative model for end stage liver disease (MELD) and Child-Turcotte-Pugh (CTP) scores appeared to be predictive of postoperative risks. Portal hypertension and surgery in the emergency setting were associated with extra increased mortality and morbidity rates.

CONCLUSION

This systematic review of the literature showed that in patients with liver cirrhosis who undergo non-hepatic surgery, postoperative morbidity and mortality rates varied greatly depending on severity of the cirrhosis and the surgical procedure. However, the majority of procedures can be safely performed in patients with low MELD scores or CTP A cirrhosis without portal hypertension.

摘要

背景

本研究旨在系统回顾肝硬化患者非肝脏手术后的发病率和死亡率。

方法

在 PubMed、Embase 和 Cochrane 图书馆中,使用“肝衰竭、肝功能不全、肝硬化、肝硬化、肝硬变、手术程序、手术并发症、手术死亡率、术后并发症、手术并发症、手术风险、疝”等词进行全面检索。

结果

初次搜索后,从 5247 篇文章中选择了 46 篇文章。文章提供的证据水平差异很大。与非肝硬化患者相似的手术相比,肝硬化患者的非肝脏手术导致术后发病率和死亡率增加。胆囊切除术和脐疝和腹股沟疝修补术与最低的发病率和死亡率相关,而胰腺手术、心血管手术和创伤手术则与之相关。术前终末期肝病模型(MELD)和Child-Turcotte-Pugh(CTP)评分似乎可以预测术后风险。门静脉高压和急诊手术与额外增加的死亡率和发病率有关。

结论

对文献的系统回顾表明,在接受非肝脏手术的肝硬化患者中,术后发病率和死亡率因肝硬化严重程度和手术程序而异。然而,大多数手术可以在低 MELD 评分或 CTP A 肝硬化且无门静脉高压的患者中安全进行。

相似文献

1
Morbidity and mortality related to non-hepatic surgery in patients with liver cirrhosis: a systematic review.肝硬化患者非肝脏手术相关的发病率和死亡率:一项系统综述。
Best Pract Res Clin Gastroenterol. 2012 Feb;26(1):47-59. doi: 10.1016/j.bpg.2012.01.010.
2
The measurement and monitoring of surgical adverse events.手术不良事件的测量与监测
Health Technol Assess. 2001;5(22):1-194. doi: 10.3310/hta5220.
3
Nutritional support for liver disease.肝病的营养支持
Cochrane Database Syst Rev. 2012 May 16;2012(5):CD008344. doi: 10.1002/14651858.CD008344.pub2.
4
Perioperative beta-blockers for preventing surgery-related mortality and morbidity.围手术期使用β受体阻滞剂预防手术相关的死亡率和发病率。
Cochrane Database Syst Rev. 2018 Mar 13;3(3):CD004476. doi: 10.1002/14651858.CD004476.pub3.
5
Nitrates for the prevention of cardiac morbidity and mortality in patients undergoing non-cardiac surgery.硝酸盐类药物用于预防非心脏手术患者的心脏发病率和死亡率。
Cochrane Database Syst Rev. 2016 Aug 4;2016(8):CD010726. doi: 10.1002/14651858.CD010726.pub2.
6
Granulocyte colony-stimulating factor with or without stem or progenitor cell or growth factors infusion for people with compensated or decompensated advanced chronic liver disease.粒细胞集落刺激因子联合或不联合干细胞或祖细胞或生长因子输注治疗代偿期或失代偿期晚期慢性肝病患者。
Cochrane Database Syst Rev. 2023 Jun 6;6(6):CD013532. doi: 10.1002/14651858.CD013532.pub2.
7
Perioperative increase in global blood flow to explicit defined goals and outcomes following surgery.围手术期将全身血流增加至明确界定的目标并实现术后特定结果。
Cochrane Database Syst Rev. 2012 Nov 14;11(11):CD004082. doi: 10.1002/14651858.CD004082.pub5.
8
Intravenous versus inhalational maintenance of anaesthesia for postoperative cognitive outcomes in elderly people undergoing non-cardiac surgery.非心脏手术老年患者术后认知结局:静脉麻醉维持与吸入麻醉维持的比较
Cochrane Database Syst Rev. 2018 Aug 21;8(8):CD012317. doi: 10.1002/14651858.CD012317.pub2.
9
Non-invasive diagnostic assessment tools for the detection of liver fibrosis in patients with suspected alcohol-related liver disease: a systematic review and economic evaluation.疑似酒精性肝病患者肝纤维化无创诊断评估工具的系统评价和经济评估。
Health Technol Assess. 2012;16(4):1-174. doi: 10.3310/hta16040.
10
L-ornithine L-aspartate for prevention and treatment of hepatic encephalopathy in people with cirrhosis.L-鸟氨酸L-天冬氨酸用于预防和治疗肝硬化患者的肝性脑病。
Cochrane Database Syst Rev. 2018 May 15;5(5):CD012410. doi: 10.1002/14651858.CD012410.pub2.

引用本文的文献

1
Association of ALBI Grade, APRI Score, and ALBI-APRI Score with Postoperative Outcomes among Patients with Liver Cirrhosis after Non-hepatic Surgery.非肝脏手术患者肝硬化患者中ALBI分级、APRI评分及ALBI-APRI评分与术后结局的相关性
Acta Med Philipp. 2025 Jul 31;59(10):74-84. doi: 10.47895/amp.vi0.9715. eCollection 2025.
2
Transjugular diagnostic procedures in hepatology: Indications, techniques and interpretation.肝病学中的经颈静脉诊断程序:适应证、技术与解读
JHEP Rep. 2025 Apr 29;7(8):101437. doi: 10.1016/j.jhepr.2025.101437. eCollection 2025 Aug.
3
Pre-Operative Assessment of Patients with Cirrhosis for Extrahepatic Surgery.
肝硬化患者肝外手术的术前评估
Curr Hepatol Rep. 2025;24(1):25. doi: 10.1007/s11901-025-00697-4. Epub 2025 Jun 4.
4
The Safety and Efficacy of Anticancer Therapy in Breast Cancer Patients with Liver Cirrhosis.抗癌疗法对肝硬化乳腺癌患者的安全性与有效性
Cancer Manag Res. 2025 Mar 19;17:639-650. doi: 10.2147/CMAR.S503109. eCollection 2025.
5
Muscle-Invasive Bladder Cancer in Patients with Liver Cirrhosis: A Review of Pertinent Considerations.肝硬化患者的肌肉浸润性膀胱癌:相关考量综述
Bladder Cancer. 2021 Aug 31;7(3):261-278. doi: 10.3233/BLC-211536. eCollection 2021.
6
Not just a clearance: Surgical risk in patients with cirrhosis.不仅仅是清除率:肝硬化患者的手术风险
Clin Liver Dis (Hoboken). 2024 Mar 7;23(1):e0109. doi: 10.1097/CLD.0000000000000109. eCollection 2024 Jan-Jun.
7
The association of perioperative blood transfusion with survival outcomes after major cancer surgery: a population-based cohort study in South Korea.围手术期输血与重大癌症手术后生存结果的关联:韩国一项基于人群的队列研究。
Surg Today. 2024 Jul;54(7):712-721. doi: 10.1007/s00595-023-02783-w. Epub 2024 Jan 4.
8
Guidance document: risk assessment of patients with cirrhosis prior to elective non-hepatic surgery.指导文件:择期非肝脏手术前肝硬化患者的风险评估
Frontline Gastroenterol. 2023 Mar 8;14(5):359-370. doi: 10.1136/flgastro-2023-102381. eCollection 2023.
9
Clinical Guideline on Perioperative Management of Patients with Advanced Chronic Liver Disease.晚期慢性肝病患者围手术期管理临床指南
Life (Basel). 2023 Jan 3;13(1):132. doi: 10.3390/life13010132.
10
Deep attenuation transducer to measure liver stiffness in obese patients with liver disease.深度衰减探头测量肝病肥胖患者的肝脏硬度。
J Med Ultrason (2001). 2023 Jan;50(1):63-72. doi: 10.1007/s10396-022-01270-y. Epub 2022 Dec 16.